Evidence map›Paper›PMID 38689927›Full record

Article3D printing and additive manufacturing2024

Optimization of a High Internal Phase Emulsion-Based Resin for Use in Commercial Vat Photopolymerization Additive Manufacturing.

Nihan Sengokmen Ozsoz, Samand Pashneh-Tala, Frederik Claeyssens

Abstract read
In one paragraph

Article in 3D printing and additive manufacturing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Effective and new technologies in kidney tissue engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nihan Sengokmen OzsozDepartment of Materials Science and Engineering, Kroto Research Institute, The University of Sheffield, Sheffield, United Kingdom.ORCID https://orcid.org/0000-0002-2000-7408
Samand Pashneh-TalaDepartment of Materials Science and Engineering, Kroto Research Institute, The University of Sheffield, Sheffield, United Kingdom.
Frederik ClaeyssensDepartment of Materials Science and Engineering, Kroto Research Institute, The University of Sheffield, Sheffield, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High internal phase emulsions (HIPEs) are potential stereolithography-based resins for producing innovative lightweight porous materials; however, the use of these resins has only been shown in bespoke stereolithography setups. These studies indicated that HIPEs tend to scatter the light during structuring through stereolithography, and can produce poorly defined and low-resolution structures, but the inclusion of light absorbers can drastically increase the printing resolution. In this study, we focused on the inclusion of biocompatible light absorbers within the resin and the compatibility of those resins with a commercial vat photopolymerization additive manufacturing (or stereolithography) setup. A surfactant (hypermer)-stabilized water-in-oil emulsion based on 2-ethylhexyl-acrylate and isobornyl-acrylate was used. For the light absorbers, both hydrophobic (beta-carotene) and hydrophilic (tartrazine) molecules were used, which dissolve in the organic phase and aqueous phase, respectively. It was found that using a combination of both beta-carotene and tartrazine provided the best stereolithography-based 3D printing resolution. In addition, the emulsion was stable for the duration of the printing process and showed a porous polyHIPE structure with open surface porosity. The formulation of these HIPE-based resins permits them to be used in a wide range of applications since complex structures could be fabricated from HIPEs.

Indexed as

3D printinglight absorberpolyHIPEstereolithographyvat photopolymerization

Identifiers

PMID38689927
PMCPMC11057525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.